ClinicalTrials.Veeva

Menu

Evaluating the Efficacy and Feasibility of a Novel Wireless ECG Recording System in Monitoring Patients After Atrial Fibrillation Ablation Procedure (iTransmit)

NeuroTherapia, Inc. logo

NeuroTherapia, Inc.

Status

Completed

Conditions

Paroxysmal Atrial Fibrillation
Persistent Atrial Fibrillation

Study type

Observational

Funder types

Other

Identifiers

Details and patient eligibility

About

The investigators goal in this study is to examine the feasibility and efficacy of AliveCor iphone case monitoring device in monitoring patients after AF ablation by comparing transmissions using Alive Cor with transmissions from a traditional transtelephonic monitor (TTM).

A secondary goal is to assess the ease of use of AliveCor device compared to traditional TTM system from the patient's perspective

Enrollment

60 patients

Sex

All

Volunteers

No Healthy Volunteers

Inclusion criteria

  1. Male or female between > 18 and < 75 years of age
  2. Paroxysmal or persistent atrial fibrillation
  3. Scheduled to undergo an AF ablation procedure
  4. Already has iPhone 4 or iPhone 4S with data plan
  5. Willing to use the iPhone Alive Cor case
  6. Written informed consent

Exclusion criteria

  1. Unable or unwilling to use the Alive Cor case for their iPhone or iPhone 4S
  2. Residing outside the United States

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems